NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Yeah, management has played this very poorly.

I very much doubt there's anything found during the investigation that necessarily needs to be disclosed for legal reasons, so there's some comfort in that. But since they did a formal investigation, the lawyers probably found some transactions/disclosures that were less than satisfactory, and may need to be disclosed in a 10Q. So maybe, they're slow playing the investigation and its release for that reason?

But the worst part is the level of uncertainty this has created, which has played straight into the hands of the bad actors that have maligned this company. Although many of the problems are not directly the fault of management, I do believe they've severally compounded the problems - just my humble opinion.

No way a company with a late phase III cancer treatment and pending Big Pharma collaborations/JVs should be sitting on a market cap < $50 million. No way.